Further, loganin inhibited metabolic abnormalities, such as hepatic steatosis and adipocyte enlargement, and increased the serum levels of leptin and insulin in both OVX- and HFD-induced obesity models. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.